Janet Woodcock covid-19 vaccine prevention Janet Woodcock

FDA green-lights Pfizer COVID-19 boosters for 16- and 17-year-olds

Reading now: 963
www.cidrap.umn.edu

Today the Food and Drug Administration (FDA) approved the use of the Pfizer-BioNTech COVID-19 booster vaccine in adolescents ages 16 and 17.The group will be eligible through an emergency use authorization (EUA) for a third dose of the mRNA vaccine 6 months after their initial vaccination series.

Acting FDA Commissioner Janet Woodcock, MD, said the announcement will come in time to protect families during the holidays."As people gather indoors with family and friends for the holidays, we can't let up on all the preventive public health measures that we have been taking during the pandemic.

With both the delta and omicron variants continuing to spread, vaccination remains the best protection against COVID-19," Woodcock said in a press

Read more on cidrap.umn.edu
The website covid-19.rehab is an aggregator of news from open sources. The source is indicated at the beginning and at the end of the announcement. You can send a complaint on the news if you find it unreliable.

Related News

DMCA